🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study will evaluate the efficacy, safety, tolerability, and effect on ...
Status
Completed
Location
Multiple Locations
Start Date
2004-11
Trial ID
NCT02608073
Treatments Being Tested
RATIONALE: Radiation therapy uses high-energy x-rays to kill tumor cells. D...
Status
Completed
Location
Szent Laszlo Korhaz
Start Date
2009-03
Trial ID
NCT00869570
Treatments Being Tested
GERICO 09/0907 is a Phase II multicentric trial evaluating the toxicity and...
Status
Completed
Location
Centre Paul Papin
Start Date
2009-12
Trial ID
NCT01262469
Treatments Being Tested
The goal of this study is to find out if the experimental product, sacituzu...
Status
Recruiting
Location
Alabama Oncology
Start Date
2022-12-12
Trial ID
NCT05633654
Treatments Being Tested
The purpose of this research study is to find out how safe and effective is...
Status
Recruiting
Location
University of Miami
Start Date
2022-10-05
Trial ID
NCT05412082
This is a prospective, open-label, randomized phase III study assessing adj...
Status
Completed
Location
Hospital General Universitario de Elche
Start Date
2006-01
Trial ID
NCT00130533
Treatments Being Tested
This study will compare RC48-ADC to physician choice standard treatment. Pa...
Status
Unknown
Location
Oncology Hospital, Chinese Academy of Medical Sciences
Start Date
2020-09-29
Trial ID
NCT04400695
This is a phase 2, randomized study where the aim of the study is to invest...
Status
Completed
Location
Oslo University Hospital
Start Date
2016-06
Trial ID
NCT02978612
Treatments Being Tested
Angiogenesis is essential for the growth of large tumor. A number of anti-a...
Status
Completed
Location
GBG Forschungs GmbH
Start Date
2010-10
Trial ID
NCT01498458
Treatments Being Tested
The purpose of this study is to evaluate the efficacy of pembrolizumab (MK-...
Status
Completed
Location
Afflilated Hospital of Bengbu Medical College-Surgical Oncology (Site 0638)
Start Date
2020-07-29
Trial ID
NCT04882241
Treatments Being Tested